Int J Audiol:住院患者的突发神经性耳聋患病率增加分析

2019-06-27 AlexYang MedSci原创

最近,有研究人员进行了为期14年的研究来调查突发神经性耳聋流行病学发病率情况。研究是一个回顾性代表性研究。住院患者的SSNHL诊断数据时间范围为2000年到2013年,数据来源于中国台湾健康研究数据库。研究发现,总共有31258名患者包括在研究中。平均的年龄为50.30±16.70岁。男性(53.5%)诊断为SSNHL的比例要比女性(46.5%)诊断为SSNHL的概率更高。其中,出现SSNHL的患

最近,有研究人员进行了为期14年的研究来调查突发神经性耳聋流行病学发病率情况。

研究是一个回顾性代表性研究。住院患者的SSNHL诊断数据时间范围为2000年到2013年,数据来源于中国台湾健康研究数据库。研究发现,总共有31258名患者包括在研究中。平均的年龄为50.30±16.70岁。男性(53.5%)诊断为SSNHL的比例要比女性(46.5%)诊断为SSNHL的概率更高。其中,出现SSNHL的患者的年龄集中于45岁到64岁之间。从2000年的奥2013年,SSNHL的粗略发生率为每十万人9.76。每年的患病率从2000年到2013年稳定增长,2000年为每十万人5.15,2013年为每十万人13.97,且统计学上具有显著性(p<0.001)。

最后,研究人员指出,他们为期14年的调查研究表明了SSNHL的发病率具有增加的趋势。因此,需要额外的治疗方法来改善预后,并阐明该疾病的潜在机制。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2035437, encodeId=5afb203543e67, content=<a href='/topic/show?id=d382e42956d' target=_blank style='color:#2F92EE;'>#神经性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74295, encryptionId=d382e42956d, topicName=神经性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Sun Nov 17 04:30:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250626, encodeId=05ea12506265b, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Sat Jun 29 14:30:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368562, encodeId=9a203685625e, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Sat Jun 29 06:29:01 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368498, encodeId=334b3684980a, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Fri Jun 28 07:31:08 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368485, encodeId=474636848535, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Thu Jun 27 23:50:58 CST 2019, time=2019-06-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2035437, encodeId=5afb203543e67, content=<a href='/topic/show?id=d382e42956d' target=_blank style='color:#2F92EE;'>#神经性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74295, encryptionId=d382e42956d, topicName=神经性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Sun Nov 17 04:30:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250626, encodeId=05ea12506265b, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Sat Jun 29 14:30:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368562, encodeId=9a203685625e, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Sat Jun 29 06:29:01 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368498, encodeId=334b3684980a, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Fri Jun 28 07:31:08 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368485, encodeId=474636848535, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Thu Jun 27 23:50:58 CST 2019, time=2019-06-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2035437, encodeId=5afb203543e67, content=<a href='/topic/show?id=d382e42956d' target=_blank style='color:#2F92EE;'>#神经性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74295, encryptionId=d382e42956d, topicName=神经性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Sun Nov 17 04:30:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250626, encodeId=05ea12506265b, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Sat Jun 29 14:30:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368562, encodeId=9a203685625e, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Sat Jun 29 06:29:01 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368498, encodeId=334b3684980a, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Fri Jun 28 07:31:08 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368485, encodeId=474636848535, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Thu Jun 27 23:50:58 CST 2019, time=2019-06-27, status=1, ipAttribution=)]
    2019-06-29 thm112988

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2035437, encodeId=5afb203543e67, content=<a href='/topic/show?id=d382e42956d' target=_blank style='color:#2F92EE;'>#神经性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74295, encryptionId=d382e42956d, topicName=神经性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Sun Nov 17 04:30:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250626, encodeId=05ea12506265b, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Sat Jun 29 14:30:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368562, encodeId=9a203685625e, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Sat Jun 29 06:29:01 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368498, encodeId=334b3684980a, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Fri Jun 28 07:31:08 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368485, encodeId=474636848535, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Thu Jun 27 23:50:58 CST 2019, time=2019-06-27, status=1, ipAttribution=)]
    2019-06-28 百草

    666

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2035437, encodeId=5afb203543e67, content=<a href='/topic/show?id=d382e42956d' target=_blank style='color:#2F92EE;'>#神经性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74295, encryptionId=d382e42956d, topicName=神经性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=927d310, createdName=hywen7326, createdTime=Sun Nov 17 04:30:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250626, encodeId=05ea12506265b, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Sat Jun 29 14:30:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368562, encodeId=9a203685625e, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Sat Jun 29 06:29:01 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368498, encodeId=334b3684980a, content=666, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/04/2540fb84decb81d47a7f2868070e6cbd.jpg, createdBy=ed3f2205793, createdName=百草, createdTime=Fri Jun 28 07:31:08 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368485, encodeId=474636848535, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Thu Jun 27 23:50:58 CST 2019, time=2019-06-27, status=1, ipAttribution=)]
    2019-06-27 orangesking

    0

相关资讯

2018 JBDS-IP指南:糖尿病住院患者的自我管理

2018年6月,英国糖尿病协会联合住院治疗组(JBDS-IP)发布了糖尿病住院患者的自我管理指南,文章主要目的是通过有效的自我管理提高住院糖尿病患者的经验和安全性。指南主要内容涉及糖尿病自我管理的原理,糖尿病专家小组的作用,自我管理的标准,患者教育,血糖管理等。

NEJM:利伐沙班用于住院患者出院后的血栓预防疗效分析

由此可见,对于出院后45天的患者,利伐沙班相比于安慰剂并不能显著降低静脉血栓栓塞引起的症状性静脉血栓栓塞和死亡风险,但大出血的发生率很低。

2018 SHM共识声明:提高住院患者急性非癌性疼痛应用阿片类药物的安全性

2018年4月,医院医学会(SHM)发布了提高住院患者急性非癌性疼痛应用阿片类药物的安全性的共识声明。医院的临床医生经常治疗急性非癌性疼痛,尽管阿片类药物的应用是有益的,但是需要平衡风险和获益。本文主要针对提供住院患者急性非癌性疼痛应用阿片类药物的安全性提出16条建议,涵盖了是否在医院内应用阿片类药物,怎样改善住院期间应用阿片类药物的安全性以及改善出院患者阿片类药物处方安全性。

Am J Gastroenterol:白蛋白对肝硬化住院患者低钠血症的影响

存在低钠血症的肝硬化患者,在接受静脉注射白蛋白后,有更高的低钠血症的逆转率(独立于肾功能和基线钠水平),而低钠血症的逆转与30天生存率的提高有关。

Eur J Clin Pharmacol:快来看呀!房颤住院患者更具代表性的直接口服抗凝药试验

2017年发表在《Eur J Clin Pharmacol》的一项由澳大利亚科学家进行的横断面研究,考察了房颤(AF)住院患者中直接口服抗凝药(DOACs)临床试验的代表性。

Int J Cardiol:心血管疾病住院患者的合并症趋势分析!

由此可见,在因心血管疾病住院的患者中合并症是非常普遍的,尤其是HF和PAD患者。在老年患者中,随着时间的推移,患病率增加。心血管疾病是最常见的合并症,虽然在研究期间其患病率有所下降,而癌症的患病率有所增加。